Medindia

X

Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications

Tuesday, September 11, 2007 General News J E 4
Advertisement
MOUNTAIN VIEW, Calif., Sept. 10 Demonstratingthe success of its low-power and power-efficient programmable technologies,Actel Corporation today announced that Mindray Medical International Limited(NYSE: MR), China's leading developer and manufacturer of medical devices, haschosen Actel's flash-based ProASIC3 field-programmable gate arrays (FPGAs) forimplementation in its portable patient monitoring systems. Selected for thelow-power, enhanced security, performance, and firm-error immunity it offers,the 60,000-gate ProASIC3 A3P060 is being deployed to provide the highestpossible levels of secure patient data management.

Following the successful deployment of Actel's ProASIC3, Mindray plans tocontinue to leverage Actel flash-based FPGAs in next-generation products,including other patient monitoring devices, diagnostic laboratory instrumentsand ultrasound imaging systems. Actel expects that IGLOO, its award-winning,low-power, flash-based FPGA, will be implemented in Mindray's next productrelease. Mindray also plans to incorporate Actel's ARM processor-enabled,flash-based FPGAs into their medical devices.

"This partnership helps advance our portable patient monitor line bybringing us the reliable low-power and security functionalities needed toeliminate power surges and errors associated with SRAM-based solutions," saidMr. Li Yao, Mindray's manager of R&D. "Actel's flash-based solutions, such asthe [A3P060] ProASIC3, have leading power, security and radiation resistancecapabilities that far exceed alternative FPGA technologies."

Mindray's comprehensive portfolio of patient monitoring systems ranges insecurity complexity from those that contain three to four security modules tothose that contain 12. Each module is designed to monitor and control thesecurity of one element of a patient's data, such as heart rate and bloodpressure etc

"Mindray's selection of our ProASIC3 devices in its industry-leading,high-quality portable patient monitoring systems underscores the advantagesthat flash-based FPGAs provide for today's portable applications," said RickLain, director of sales, Asia Pacific at Actel. "Providing unprecedented lowpower, small footprint and security in a single chip, Actel's feature-richFPGAs uniquely possess features highly sought after by the ever-growinginternational community of portable electronics designers."

About Mindray

Mindray Medical International Limited is a leading developer, manufacturerand marketer of medical devices in China with a significant and growingpresence worldwide. Established in 1991, Mindray offers a broad range ofproducts across three primary business segments: patient monitoring devices,diagnostic laboratory instruments, and ultrasound imaging systems. Mindray isheadquartered in Shenzhen, China, and has 29 local sales and service officesin China, as well as sales and service offices in Boston, Istanbul, London,Mumbai, Seattle and Vancouver. For more information, please visithttp://www.mindray.com.

About Actel

Attacking power consumption from both the chip and the system levels,Actel power-smart programmable solutions enable power-efficient design. Thecompany is the leader in single-chip FPGA solutions. Founded in 1985, Actelemploys more than 550 people worldwide. The Company is traded on the NasdaqNational Market under the symbol ACTL. For more information, visithttp://www.actel.com.

The Actel name and logo are registered trademarks of Actel Corporation.The Actel IGLOO and Actel Fusion names and logos are trademarks of ActelCorporation. All other trademarks and servicemarks are the property of theirrespective owners.

SOURCE Actel Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cheryl Hines and Quaker to Help 'Curb' High Choles...
S
Nventa Initiates HspE7 Phase 1 Cervical Dysplasia ...